Louisa Petropoulos
Director de Operaciones en Centre For Commercialization of Cancer Immunotherapy .
Perfil
Louisa Petropoulos is currently the Director of Business Development & Operations at the Centre For Commercialization of Cancer Immunotherapy since 2016.
Prior to this, she worked as a Director at Aegera Therapeutics, Inc. and as an Investment Manager at Innovatech Montreal, Inc. She also worked as a Principal at Multiple Capital, Inc. from 2005 to 2008.
Dr. Petropoulos holds a doctorate degree from McGill University.
Cargos activos de Louisa Petropoulos
| Empresas | Cargo | Inicio |
|---|---|---|
Centre For Commercialization of Cancer Immunotherapy
 Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Director de Operaciones | 01/08/2016 |
Antiguos cargos conocidos de Louisa Petropoulos.
| Empresas | Cargo | Fin |
|---|---|---|
Multiple Capital, Inc.
 Multiple Capital, Inc. Investment ManagersFinance Founded in 2005, formerly Société Innovatech du Grand Montréal, Multiple Capital is a Montréal-based venture capital subsidiary of Collier Capital Ltd. | Inversor de Capital Privado | 01/09/2008 |
Innovatech Montreal, Inc.
 Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Inversor de Capital Privado | 30/06/2005 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Director/Miembro de la Junta | - |
Formación de Louisa Petropoulos.
| McGill University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Multiple Capital, Inc.
Multiple Capital, Inc. Investment ManagersFinance Founded in 2005, formerly Société Innovatech du Grand Montréal, Multiple Capital is a Montréal-based venture capital subsidiary of Collier Capital Ltd. | Finance |
Innovatech Montreal, Inc.
Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Finance |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. |
- Bolsa de valores
- Insiders
- Louisa Petropoulos
